Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blinatumomab's Outcome On Serologic Titers and Efficacy of Revaccination

NCT07422337 is registered in ClinicalTrials.gov with Arkansas Children's Hospital Research Institute as lead sponsor.

NCT NCT07422337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07422337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blinatumomab's Outcome On Serologic Titers and Efficacy of Revaccination
Lead sponsor
Arkansas Children's Hospital Research Institute
Phase
Observational
Overall status
Recruiting
Start date
January 13, 2026
Completion date
January 31, 2029
Enrollment
300 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell acute lymphoblastic leukaemia, b-cell acute lymphoblastic leukemia, b-cell acute lymphoblastic leukemia (b-all), b-cell all, b-cell childhood acute lymphoblastic leukemia, b-cell leukemia, b-cell lymphoblastic leukemia, b-cell lymphoblastic leukemia/lymphoma